Kevin E Weddington

Array ( [id] => 11560438 [patent_doc_number] => 09622998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine' [patent_app_type] => utility [patent_app_number] => 14/743549 [patent_app_country] => US [patent_app_date] => 2015-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5650 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14743549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10692363 [patent_doc_number] => 20160038509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'Compositions and Methods for the Treatment of Addiction, Psychiatric Disorders, and Neurodegenerative Disease' [patent_app_type] => utility [patent_app_number] => 14/736619 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22489 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10191819 [patent_doc_number] => 09220712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Pharmaceutical intervention and method for treating an apraxia of speech in children' [patent_app_type] => utility [patent_app_number] => 14/736406 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6473 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059495 [patent_doc_number] => 20160256457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'METHODS FOR TREATING OR PREVENTING ACUTE VASCULAR LEAK' [patent_app_type] => utility [patent_app_number] => 14/735250 [patent_app_country] => US [patent_app_date] => 2015-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13388 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13209099 [patent_doc_number] => 10118906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Use of substituted oxadiazoles for combating phytopathogenic fungi [patent_app_type] => utility [patent_app_number] => 15/316399 [patent_app_country] => US [patent_app_date] => 2015-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25239 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 455 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10373092 [patent_doc_number] => 20150258097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF CATATONIA' [patent_app_type] => utility [patent_app_number] => 14/721296 [patent_app_country] => US [patent_app_date] => 2015-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12237 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11262125 [patent_doc_number] => 09486406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Stable preservative-free mydriatic and anti-inflammatory solutions for injection' [patent_app_type] => utility [patent_app_number] => 14/721151 [patent_app_country] => US [patent_app_date] => 2015-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 14235 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11843391 [patent_doc_number] => 09730930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'Treatment for vitiligo' [patent_app_type] => utility [patent_app_number] => 14/715322 [patent_app_country] => US [patent_app_date] => 2015-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 19253 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12253029 [patent_doc_number] => 09925159 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-03-27 [patent_title] => 'D-serine treatment for neurological disorders that cause seizures' [patent_app_type] => utility [patent_app_number] => 14/713309 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 3200 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11522736 [patent_doc_number] => 09606131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Assays and methods of treatment relating to vitamin D insufficiency' [patent_app_type] => utility [patent_app_number] => 14/709315 [patent_app_country] => US [patent_app_date] => 2015-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 54058 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11491421 [patent_doc_number] => 20170065607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/308525 [patent_app_country] => US [patent_app_date] => 2015-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 23292 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346097 [patent_doc_number] => 20150231102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'METHODS OF TREATING MIXED DYSLIPIDEMIA' [patent_app_type] => utility [patent_app_number] => 14/704329 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26750 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14704329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13645761 [patent_doc_number] => 09849179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => Methods for topical delivery of prostaglandins to subcutaneous fat [patent_app_type] => utility [patent_app_number] => 14/702365 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29792 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14702365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12364104 [patent_doc_number] => 09956228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds [patent_app_type] => utility [patent_app_number] => 15/308540 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 68 [patent_no_of_words] => 26366 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10428871 [patent_doc_number] => 20150313881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'Therapeutic Methods for Type I Diabetes' [patent_app_type] => utility [patent_app_number] => 14/699666 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 39463 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11804484 [patent_doc_number] => 09545448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-17 [patent_title] => 'Tamper resistant pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 14/670651 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10124 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14670651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11634017 [patent_doc_number] => 09655971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-23 [patent_title] => 'Tamper resistant pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 14/670658 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10124 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14670658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12008570 [patent_doc_number] => 09801869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Method of inhibiting constitutively active phosphorylated FLT3 kinase' [patent_app_type] => utility [patent_app_number] => 14/671613 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 11332 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11641049 [patent_doc_number] => 09662399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Tamper resistant pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 14/670662 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10124 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14670662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311554 [patent_doc_number] => 20150196556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'Tamper Resistant Pharmaceutical Formulations' [patent_app_type] => utility [patent_app_number] => 14/670654 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10076 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14670654 [rel_patent_id] =>[rel_patent_doc_number] =>)